双鹭药业：公司研发五年前开始加大创新药和生物药的比重

Group 1 - The core viewpoint is that not all generic drugs are in highly competitive categories, and there are distinctions in quality among them [2] - The pharmaceutical market in China is expected to primarily focus on generic drugs due to its status as a developing country [2] - The company has been increasing its focus on innovative drugs and biopharmaceuticals for the past five years, with plans for new innovative product submissions in the future [2]